Dexcom
Edit

Dexcom

https://www.dexcom.com/
Last activity: 08.09.2025
Active
Categories: ContentHealthTechInformationManagementMedTechPageProductSensorsServiceTime
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs approximately 6,000 people.
Followers
62.77K
Website visits
2.1M /mo.
Mentions
140
Location: United States, California, Sorrento Valley
Employees: 5001-10000
Phone: +1 888-738-3646
Founded date: 1999

Investors 3

Mentions in press and media 140

DateTitleDescription
08.09.2025Signos Launches First FDA-Cleared Glucose Monitoring System for Weight ManagementWhat You Should Know: – Signos, a metabolic and weight management company, has announced the launch of the Signos Glucose Monitoring System. – The system is the first FDA-cleared, over-the-counter glucose monitoring system for weight manage...
06.09.2025ViCentra Secures $85 Million to Revolutionize Diabetes Care with Kaleido Patch Pump, Eyes U.S. MarketViCentra, a European MedTech firm, raised $85 million in Series D funding. This capital will accelerate production and launch of its Kaleido 2 patch pump across Europe. It also prepares for critical U.S. market entry. Kaleido offers a uniqu...
05.09.2025Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pumpViCentra, an Utrecht-based medical device company innovating insulin delivery for people with diabetes, announced the successful close of a €72.4 million Series D financing to accelerate manufacturing and launch the Kaleido 2 patch pump in ...
05.09.2025ViCentra: $85 Million Raised To Expand Kaleido Patch Pump And Advance Global Diabetes CareViCentra, a European medical technology company focused on transforming insulin delivery for people living with diabetes, has announced the close of an $85 million Series D funding round. The round was led by Innovation Industries and inclu...
29.08.2025Discuss Debuts “Vibe Coding” and Hybrid AI + Human Market Insight PlatformAs AI-moderated interviews reshape qualitative research, many companies frame it as a choice between automation or human connection. Discuss, the only global market insights platform proven to deliver both, today announced new features that...
27.08.2025Discuss Introduces “Vibe Coding” and Hybrid AI + Human Market Insight PlatformAs AI-moderated interviews reshape qualitative research, many companies frame it as a choice between automation or human connection. , the only global market insights platform proven to deliver both, announced new features that cement the h...
20.08.2025FDA approves first-ever glucose monitoring system for weight loss from SignosThe Food and Drug Administration approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, a new option for Americans to manage their weight. Any patient can now purchase a Signos membership to ...
01.08.2025Sava Technologies Transforms Health Monitoring with Wearable Biosensor InnovationSava Technologies, a London-based MedTech pioneer, secured $19 million in Series A funding. This investment propels its revolutionary wearable biosensor. The device offers pain-free, real-time glucose monitoring. Early clinical trials show ...
31.07.2025“Glucose is only the beginning”: London-based Sava Technologies raises €16.6 million for its wearable microsensor technologySava Technologies Ltd., a British MedTech startup innovating real-time molecular health monitoring, today announced €16.6 million in Series A funding to accelerate regulatory approval and commercialisation of its next-generation wearable. T...
18.06.2025CeQur® Marks 10 Million Mealtime Injections Replaced and Highlights Commercial ExpansionCeQur Simplicity™ CeQur announces that its wearable insulin patch, CeQur Simplicity™, has replaced 10 million mealtime insulin injections. The company continues its momentum with expanded clinical access and key leadership appointments. HOR...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In